Mary Beckerle, PhD, serves as CEO of Huntsman Cancer Institute, a comprehensive cancer research and clinical care facility at the University of Utah. Under her leadership, HCI has doubled the size of its hospital and research facilities, has been recognized with the highest designation for research excellence by the National Cancer Institute, and has been named a top cancer hospital by US News and World Report.

An internationally recognized scientist focused on fundamental aspects of cancer cell biology and Ewing's sarcoma, Mary received the 2018 Alfred G. Knudson Award from the National Cancer Institute. She is a respected leader in science and policy, having served as president of the American Society of Cell Biology, on the board of directors of the American Association for Cancer Research, on the advisory committee to the NIH director, and on the Blue Ribbon Panel for Joe Biden's Cancer Moonshot initiative.

Mary currently serves on the medical advisory board of the Howard Hughes Medical Institute, advisory boards for Dana Farber / Harvard Cancer Center and research institutes in India and Singapore, and the boards of directors of Huntsman Corp. and Johnson & Johnson. She is an elected fellow of the American Academy of Arts and Sciences and the American Philosophical Society.